Department of Radiology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.
Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Abdom Radiol (NY). 2023 Jun;48(6):1891-1899. doi: 10.1007/s00261-023-03884-3. Epub 2023 Mar 24.
To report the detection rate of colorectal tumors with computed tomography (CT) performed within 1 year before diagnosis for indications other than colon abnormalities. Strategies to improve cancer detection are reported.
Two board-certified, subspecialty-trained abdominal radiologists retrospectively reviewed patient health records and CT images with knowledge of tumor location/size. Patients were classified into 3 groups: prospective (colon abnormality suggesting neoplasm documented in radiologic report), retrospective (not documented in radiologic report but detected in our retrospective review of CT images), and undetected (neither prospectively nor retrospectively detected). Retrospective detection confidence and morphologic characteristics of each tumor were also recorded.
Of 209 included patients, 106 (50.7%) had prospectively detected tumors, 66 (31.6%) had retrospectively detected tumors, and 37 (17.7%) had undetected tumors. Asymmetric bowel wall thickening and polypoid masses were present more often in the retrospective group than in the prospective group (27% vs. 10.5% and 26% vs. 17.1%, respectively). Tumors in the ascending colon were more likely to be detected retrospectively than prospectively (odds ratio, 2.75; 95% CI 1.07-7.08; P = 0.04). Undetected tumors were smaller on average (2.9 cm) than prospective (6.0 cm) and retrospective (4.9 cm) tumors (P = 0.03). Detection confidence was lower for retrospectively detected tumors than for prospectively detected tumors (P = 0.03). Indications other than abdominal pain were most common for retrospectively detected tumors (P = 0.03). Use of intravenous contrast material was lowest in the undetected group (P = 0.003). The prospective group had more pericolonic abnormalities, regional/retroperitoneal lymph node involvement (P < 0.001), and distant metastases than did the retrospective group (P = 0.01).
Half of all colorectal tumors were not detected prospectively. Radiologists should perform meticulous colon tracking regardless of the indication for CT. The right colon merits additional examination. Polypoid and asymmetric morphologic characteristics were most often overlooked, but these characteristics can be learned to improve detection.
报告在诊断前 1 年内因非结肠异常原因进行的计算机断层扫描(CT)检测到结直肠肿瘤的检出率。报道了提高癌症检出率的策略。
两名具有专业资质、经过专门培训的腹部放射科医生,在了解肿瘤位置/大小的情况下,对患者的健康记录和 CT 图像进行回顾性分析。患者被分为 3 组:前瞻性(放射学报告中记录有提示肿瘤的结肠异常)、回顾性(放射学报告中未记录,但在我们对 CT 图像的回顾性分析中发现)和未检出(既未前瞻性检出也未回顾性检出)。还记录了每个肿瘤的回顾性检测置信度和形态特征。
在 209 名纳入的患者中,106 例(50.7%)有前瞻性检出的肿瘤,66 例(31.6%)有回顾性检出的肿瘤,37 例(17.7%)有未检出的肿瘤。不对称性肠壁增厚和息肉样肿块在回顾性组中比前瞻性组更常见(分别为 27%比 10.5%和 26%比 17.1%)。升结肠癌更有可能被回顾性检出,而非前瞻性检出(比值比,2.75;95%置信区间,1.07-7.08;P=0.04)。未检出的肿瘤平均直径小于前瞻性检出的肿瘤(2.9cm)和回顾性检出的肿瘤(4.9cm)(P=0.03)。回顾性检出肿瘤的检测置信度低于前瞻性检出肿瘤(P=0.03)。与前瞻性检出肿瘤相比,回顾性检出肿瘤的最常见指征是除腹痛以外的其他症状(P=0.03)。未检出肿瘤组的静脉造影剂使用量最低(P=0.003)。前瞻性组比回顾性组有更多的结肠周围异常、区域/腹膜后淋巴结受累(P<0.001)和远处转移(P=0.01)。
一半的结直肠肿瘤未被前瞻性检出。放射科医生无论 CT 的指征如何,都应仔细进行结肠追踪。右半结肠需要进一步检查。息肉样和不对称的形态特征最常被忽视,但这些特征可以通过学习来提高检出率。